progscrape: nejm.org

A new era for medicine: successful, first of its kind, CRISPR-Cas9 gene editing in people with ATTR amyloidosis

3 years ago nejm.org

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 | NEJM

4 years ago nejm.org covid vaccine

Trial of Psilocybin versus Escitalopram for Depression | NEJM

4 years ago nejm.org psilocybin trial

Trial of Psilocybin versus Escitalopram for Depression

4 years ago nejm.org psilocybin trial

Preliminary study findings show that mRNA COVID-19 vaccines are safe for pregnant persons

4 years ago nejm.org covid mrna

Astra Zeneca vaccine does not protect against mild-to-moderate Covid-19 due to the South African variant.

4 years ago nejm.org covid vaccine

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19 | NEJM

4 years ago nejm.org covid

The Pfizer COVID-19 vaccine has proven 94 percent effective in a study involving 1.2 million people in Israel, the first peer-reviewed real world research confirming the power of mass immunization campaigns to bring the pandemic to a close.

4 years ago nejm.org covid vaccine

Single Dose of Moderna, Pfizer COVID-19 Vaccine Nearly as Effective as Two Doses.

4 years ago nejm.org covid vaccine

The use of naltrexone plus bupropion to treat methamphetamine use disorder

4 years ago nejm.org